BioAegis Therapeutics, Inc. — Form D

BioAegis Therapeutics, Inc. of Morristown, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-11. The offering totals $21.8M, of which $21.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Valerie CevaDirectorMorristown, NJ
Mark DiNubileDirectorMorristown, NJ
Susan LevinsonDirectorMorristown, NJ
Valerie CevaExecutive OfficerMorristown, NJ
Mark DiNubileExecutive OfficerMorristown, NJ
Susan LevinsonExecutive OfficerMorristown, NJ
John StosselDirectorMorristown, NJ
Thomas StosselDirectorNorth Brunswick, NJ
Thomas StosselExecutive OfficerNorth Brunswick, NJ
Steven CordovanoExecutive OfficerNorth Brunswick, NJ
Steve CordovanoExecutive OfficerMorristown, NJ
Susan L LevinsonDirectorMorristown, NJ
Susan L LevinsonExecutive OfficerMorristown, NJ
Valerie L CevaDirectorNew York, NY
Valerie L CevaExecutive OfficerNew York, NY
Thomas L StosselDirectorBelmont, MA
Steven L CordovanoExecutive OfficerRowayton, CT

Other filings by this issuer (8)

FiledFormOfferingSold
2020-10-07D/A$7.0M$7.0M
2020-06-17D$5.0M$5.0M
2018-09-26D$7.0M$4.1M
2016-03-14D$5.0M$1.5M
2015-04-17D/A$8.0M
2014-02-07D/A$6.0M$3.7M
2013-02-08D/A$6.0M$3.1M
2012-04-11D$6.0M$497K

More